Table 5 Logistic regression analysis to assess the association of MMP-9 expression and PTC, TNM stages, and lymphovascular invasion
From: The role of matrix metalloproteinase-9 as a prognostic biomarker in papillary thyroid cancer
| Â | B | S.E. | P value | Odds ratio | 95% Confidence Interval | |
|---|---|---|---|---|---|---|
Patients PTC vs. MNG | MMP-9a | 0.18 | 0.07 | 0.009 | 1.20 | (1.04–1.37) |
TNM Stages III/IV vs. I/II | MMP-9a | 0.61 | 0.31 | 0.050 | 1.83 | (0.99–3.37) |
Lymphovascular invasion Yes vs. No | MMP-9 | 1.38 | 0.44 | 0.002 | 3.97 | (1.68–9.40) |